Sm04554
Collapse
X
-
Hi mates
What's so special about this? It works with wnt?
Valproic acid (VPA), a widely used anticonvulsant, inhibits glycogen synthase kinase 3β and activates the Wnt/β-catenin pathway, which is associated with hair growth cycle and anagen induction. To assess the efficacy of topical VPA for treating androgenetic alopecia (AGA), we performed a randomized, …
I read valproic acid has been around for years & its very cheap.
Can anyone comment on this ?Leave a comment:
-
-
-
-
-
At the hair congress they will be presenting the results from the 1st phase of the clinical trial..
Safety and Efficacy of a Topical Treatment (SM04554) for Androgenetic Alopecia (AGA): Results from a Phase 1 Trial Yusuf Yazici, MD | USALeave a comment:
-
So how many trials are these guys running now? Did they already finish a clinical trial? Perhaps they will present some preliminary data on the congress on a poster whatsoever.Leave a comment:
-
-
Leave a comment:
-
Does anyone know if their drug is a topical or oral med?
I cant imagine them being such a big sponser of the congress and not presenting anything. Dude, if they even showed a product logo id flip my shytLeave a comment:
-
I feel like samumed may wait to release results from the clinical trial ending this month unitl they have the results from the new smaller trial ending in February.. But the anticipation is slowly starting to kill me lol hopefully they release something regarding the chemical or its effectiveness come the hair congressLeave a comment:
-
Good! I still strongly believe in them, when you know Wnt/b catenin act as the key cascade with others, it gives high hopes
Does someone understand the patent's world? and could explain me what does the recent patents applications publications on this 22 october , and that are concerning us, mean
B- and y -diketones and y -hydroxyketones as wnt/ b -catenin signaling pathway activators
-First why on 22 oct they are two applications of the same patent? what does that mean?
-And it's the 'same' patent that we already posted here in 2014, so what are these new ones for, or what are the différences? (though it's just 'look like' the same patent, so maybe there's could be new things in it as i don't had the time to read it)Leave a comment:
Leave a comment: